Citation map · Study

SZodixStudyAcademic Library

Dashboard Shelves Open access My library Inbox Notes Write Learn Alerts

More

Ask your library Notifications Quick cite Review

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus

8 references·16 citing·30 second hop

FromToDepth

this work references cited by second hop

References

2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited
2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
2003The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations264 cited
1997The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection168 cited
2002International application of the Incidence Rate/Window Period model150 cited
2004Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States136 cited
2003Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.126 cited
2003Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001126 cited

Cited by

2007Current risk for transfusion transmitted infections104 cited
2011Informative Dorfman Screening97 cited
2007Reducing the risk of transfusion‐transmissible viral infection through blood donor selection: the Australian experience 2000 through 200687 cited
2007Residual risk of transfusion‐transmitted viral infections in Shenzhen, China, 2001 through 2004

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

70 cited

2011Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study‐II blood centers in Brazil64 cited

2007The Risk of HIV, HBV, HCV and HTLV Infection Among Musculoskeletal Tissue Donors in Australia60 cited

2010No evidence of a significantly increased risk of transfusion‐transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12‐month deferral for men who have had sex with men (CME)57 cited

2014Infectivity of blood components from donors with occult hepatitis B infection – results from an Australian lookback programme49 cited

2007Residual infectious disease risk in screened blood transfusion from a high‐prevalence population: Santa Catarina, Brazil44 cited

2018False positive viral marker results in blood donors and their unintended consequences43 cited

2012Trends in prevalence, incidence, and residual risk of major transfusion‐transmissible viral infections in United Arab Emirates blood donors: impact of individual‐donation nucleic acid testing, 2004 through 200936 cited

2013Trends in transfusion‐transmissible infections among A ustralian blood donors from 2005 to 201034 cited

2008Emerging viral threats to the Australian blood supply34 cited

2017Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk33 cited

2008Epidemiology of hepatitis B in Canadian blood donors33 cited

2011Surveillance of Transfusion-Transmissible Infections27 cited